Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.42
CAH's Cash to Debt is ranked lower than
59% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.57 vs. CAH: 0.42 )
Ranked among companies with meaningful Cash to Debt only.
CAH' s Cash to Debt Range Over the Past 10 Years
Min: 0.03  Med: 0.49 Max: 1.29
Current: 0.42
0.03
1.29
Equity to Asset 0.20
CAH's Equity to Asset is ranked lower than
84% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.40 vs. CAH: 0.20 )
Ranked among companies with meaningful Equity to Asset only.
CAH' s Equity to Asset Range Over the Past 10 Years
Min: 0.21  Med: 0.36 Max: 0.43
Current: 0.2
0.21
0.43
Interest Coverage 51.82
CAH's Interest Coverage is ranked higher than
62% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.22 vs. CAH: 51.82 )
Ranked among companies with meaningful Interest Coverage only.
CAH' s Interest Coverage Range Over the Past 10 Years
Min: 11.25  Med: 11.51 Max: 17.65
Current: 51.82
11.25
17.65
F-Score: 7
Z-Score: 4.65
M-Score: -2.40
WACC vs ROIC
6.48%
18.15%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 2.07
CAH's Operating margin (%) is ranked lower than
66% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.96 vs. CAH: 2.07 )
Ranked among companies with meaningful Operating margin (%) only.
CAH' s Operating margin (%) Range Over the Past 10 Years
Min: 0.99  Med: 1.63 Max: 2.32
Current: 2.07
0.99
2.32
Net-margin (%) 1.22
CAH's Net-margin (%) is ranked lower than
68% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.85 vs. CAH: 1.22 )
Ranked among companies with meaningful Net-margin (%) only.
CAH' s Net-margin (%) Range Over the Past 10 Years
Min: 0.33  Med: 1.20 Max: 2.22
Current: 1.22
0.33
2.22
ROE (%) 21.43
CAH's ROE (%) is ranked higher than
86% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.13 vs. CAH: 21.43 )
Ranked among companies with meaningful ROE (%) only.
CAH' s ROE (%) Range Over the Past 10 Years
Min: 5.47  Med: 17.22 Max: 24.34
Current: 21.43
5.47
24.34
ROA (%) 4.56
CAH's ROA (%) is ranked higher than
64% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.55 vs. CAH: 4.56 )
Ranked among companies with meaningful ROA (%) only.
CAH' s ROA (%) Range Over the Past 10 Years
Min: 1.33  Med: 4.49 Max: 8.29
Current: 4.56
1.33
8.29
ROC (Joel Greenblatt) (%) 113.19
CAH's ROC (Joel Greenblatt) (%) is ranked higher than
91% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 23.26 vs. CAH: 113.19 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CAH' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 19.02  Med: 46.94 Max: 110.85
Current: 113.19
19.02
110.85
Revenue Growth (3Y)(%) -0.20
CAH's Revenue Growth (3Y)(%) is ranked lower than
75% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.90 vs. CAH: -0.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CAH' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -3.2  Med: 13.20 Max: 27
Current: -0.2
-3.2
27
EBITDA Growth (3Y)(%) 8.70
CAH's EBITDA Growth (3Y)(%) is ranked higher than
56% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.70 vs. CAH: 8.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CAH' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -11.7  Med: 9.40 Max: 30
Current: 8.7
-11.7
30
EPS Growth (3Y)(%) 5.70
CAH's EPS Growth (3Y)(%) is ranked lower than
53% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.80 vs. CAH: 5.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CAH' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -15.7  Med: 7.10 Max: 30.7
Current: 5.7
-15.7
30.7
» CAH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

CAH Guru Trades in Q1 2015

Jeremy Grantham 2,400 sh (New)
Ray Dalio 70,000 sh (New)
Paul Tudor Jones 264,086 sh (+4794.11%)
Steven Cohen 105,300 sh (+81.55%)
Pioneer Investments 3,090,940 sh (+17.09%)
John Keeley 124,467 sh (+0.14%)
Vanguard Health Care Fund 5,043,241 sh (unchged)
Joel Greenblatt 235,517 sh (-3.23%)
John Buckingham 17,710 sh (-3.73%)
James Barrow 6,465,936 sh (-4.13%)
RS Investment Management 309,639 sh (-12.85%)
» More
Q2 2015

CAH Guru Trades in Q2 2015

Ray Dalio 109,300 sh (+56.14%)
Vanguard Health Care Fund 5,043,241 sh (unchged)
Jeremy Grantham Sold Out
Steven Cohen Sold Out
James Barrow 6,389,140 sh (-1.19%)
John Keeley 122,412 sh (-1.65%)
RS Investment Management 285,699 sh (-7.73%)
Pioneer Investments 2,732,113 sh (-11.61%)
Joel Greenblatt 201,203 sh (-14.57%)
John Buckingham 13,147 sh (-25.77%)
Paul Tudor Jones 18,997 sh (-92.81%)
» More
Q3 2015

CAH Guru Trades in Q3 2015

Jim Simons 685,700 sh (New)
Joel Greenblatt 260,055 sh (+29.25%)
Vanguard Health Care Fund 6,385,231 sh (+26.61%)
John Buckingham 14,447 sh (+9.89%)
James Barrow 6,057,453 sh (-5.19%)
John Keeley 114,347 sh (-6.59%)
Pioneer Investments 2,330,236 sh (-14.71%)
Ray Dalio 90,732 sh (-16.99%)
RS Investment Management 158,439 sh (-44.54%)
Paul Tudor Jones 8,700 sh (-54.20%)
» More
Q4 2015

CAH Guru Trades in Q4 2015

Pioneer Investments 2,483,349 sh (+6.57%)
John Buckingham 15,177 sh (+5.05%)
Vanguard Health Care Fund 6,385,231 sh (unchged)
James Barrow 5,845,797 sh (-3.49%)
» More
» Details

Insider Trades

Latest Guru Trades with CAH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 19.36
CAH's P/E(ttm) is ranked higher than
56% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.98 vs. CAH: 19.36 )
Ranked among companies with meaningful P/E(ttm) only.
CAH' s P/E(ttm) Range Over the Past 10 Years
Min: 6.29  Med: 15.64 Max: 72.3
Current: 19.36
6.29
72.3
Forward P/E 13.09
CAH's Forward P/E is ranked higher than
62% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.66 vs. CAH: 13.09 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 19.46
CAH's PE(NRI) is ranked higher than
57% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 23.11 vs. CAH: 19.46 )
Ranked among companies with meaningful PE(NRI) only.
CAH' s PE(NRI) Range Over the Past 10 Years
Min: 6.72  Med: 17.65 Max: 73.78
Current: 19.46
6.72
73.78
P/B 3.82
CAH's P/B is ranked lower than
87% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.10 vs. CAH: 3.82 )
Ranked among companies with meaningful P/B only.
CAH' s P/B Range Over the Past 10 Years
Min: 0.86  Med: 2.35 Max: 4.76
Current: 3.82
0.86
4.76
P/S 0.23
CAH's P/S is ranked higher than
78% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.41 vs. CAH: 0.23 )
Ranked among companies with meaningful P/S only.
CAH' s P/S Range Over the Past 10 Years
Min: 0.08  Med: 0.17 Max: 0.32
Current: 0.23
0.08
0.32
PFCF 12.43
CAH's PFCF is ranked higher than
80% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: 17.69 vs. CAH: 12.43 )
Ranked among companies with meaningful PFCF only.
CAH' s PFCF Range Over the Past 10 Years
Min: 5.8  Med: 12.02 Max: 31.45
Current: 12.43
5.8
31.45
POCF 10.65
CAH's POCF is ranked higher than
87% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 15.64 vs. CAH: 10.65 )
Ranked among companies with meaningful POCF only.
CAH' s POCF Range Over the Past 10 Years
Min: 4.68  Med: 10.10 Max: 19.4
Current: 10.65
4.68
19.4
EV-to-EBIT 13.09
CAH's EV-to-EBIT is ranked higher than
62% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.42 vs. CAH: 13.09 )
Ranked among companies with meaningful EV-to-EBIT only.
CAH' s EV-to-EBIT Range Over the Past 10 Years
Min: 5.6  Med: 10.60 Max: 25.5
Current: 13.09
5.6
25.5
EV-to-EBITDA 10.78
CAH's EV-to-EBITDA is ranked higher than
61% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.32 vs. CAH: 10.78 )
Ranked among companies with meaningful EV-to-EBITDA only.
CAH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.8  Med: 8.90 Max: 17.6
Current: 10.78
4.8
17.6
PEG 1.99
CAH's PEG is ranked higher than
57% of the 23 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.38 vs. CAH: 1.99 )
Ranked among companies with meaningful PEG only.
CAH' s PEG Range Over the Past 10 Years
Min: 1.23  Med: 5.16 Max: 156.2
Current: 1.99
1.23
156.2
Shiller P/E 23.74
CAH's Shiller P/E is ranked higher than
74% of the 23 Companies
in the Global Medical Distribution industry.

( Industry Median: 29.49 vs. CAH: 23.74 )
Ranked among companies with meaningful Shiller P/E only.
CAH' s Shiller P/E Range Over the Past 10 Years
Min: 6.6  Med: 13.53 Max: 28.92
Current: 23.74
6.6
28.92
Current Ratio 1.19
CAH's Current Ratio is ranked lower than
82% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.49 vs. CAH: 1.19 )
Ranked among companies with meaningful Current Ratio only.
CAH' s Current Ratio Range Over the Past 10 Years
Min: 1.18  Med: 1.37 Max: 1.83
Current: 1.19
1.18
1.83
Quick Ratio 0.64
CAH's Quick Ratio is ranked lower than
89% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.04 vs. CAH: 0.64 )
Ranked among companies with meaningful Quick Ratio only.
CAH' s Quick Ratio Range Over the Past 10 Years
Min: 0.53  Med: 0.66 Max: 1.15
Current: 0.64
0.53
1.15
Days Inventory 33.33
CAH's Days Inventory is ranked higher than
70% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 52.54 vs. CAH: 33.33 )
Ranked among companies with meaningful Days Inventory only.
CAH' s Days Inventory Range Over the Past 10 Years
Min: 25.37  Med: 30.52 Max: 35.94
Current: 33.33
25.37
35.94
Days Sales Outstanding 22.66
CAH's Days Sales Outstanding is ranked higher than
87% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 56.51 vs. CAH: 22.66 )
Ranked among companies with meaningful Days Sales Outstanding only.
CAH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 17.45  Med: 20.79 Max: 23.22
Current: 22.66
17.45
23.22
Days Payable 58.08
CAH's Days Payable is ranked lower than
66% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 74.19 vs. CAH: 58.08 )
Ranked among companies with meaningful Days Payable only.
CAH' s Days Payable Range Over the Past 10 Years
Min: 35.49  Med: 41.78 Max: 54.17
Current: 58.08
35.49
54.17

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.93
CAH's Dividend Yield is ranked higher than
54% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.96 vs. CAH: 1.93 )
Ranked among companies with meaningful Dividend Yield only.
CAH' s Dividend Yield Range Over the Past 10 Years
Min: 0.28  Med: 1.78 Max: 2.66
Current: 1.93
0.28
2.66
Dividend Payout 0.37
CAH's Dividend Payout is ranked higher than
67% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.34 vs. CAH: 0.37 )
Ranked among companies with meaningful Dividend Payout only.
CAH' s Dividend Payout Range Over the Past 10 Years
Min: 0.03  Med: 0.09 Max: 1.8
Current: 0.37
0.03
1.8
Dividend Growth (3y) 17.00
CAH's Dividend Growth (3y) is ranked higher than
57% of the 21 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.60 vs. CAH: 17.00 )
Ranked among companies with meaningful Dividend Growth (3y) only.
CAH' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 12.2  Med: 17.00 Max: 49.4
Current: 17
12.2
49.4
Forward Dividend Yield 1.98
CAH's Forward Dividend Yield is ranked higher than
50% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.02 vs. CAH: 1.98 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 3.90
CAH's Yield on cost (5-Year) is ranked higher than
60% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.95 vs. CAH: 3.90 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
CAH' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.57  Med: 3.60 Max: 5.37
Current: 3.9
0.57
5.37
3-Year Average Share Buyback Ratio 1.40
CAH's 3-Year Average Share Buyback Ratio is ranked higher than
81% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: -1.00 vs. CAH: 1.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CAH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -22.9  Med: 1.30 Max: 5.8
Current: 1.4
-22.9
5.8

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.28
CAH's Price/Projected FCF is ranked higher than
52% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.28 vs. CAH: 1.28 )
Ranked among companies with meaningful Price/Projected FCF only.
CAH' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.31  Med: 0.84 Max: 5.4
Current: 1.28
0.31
5.4
Price/Median PS Value 1.44
CAH's Price/Median PS Value is ranked lower than
78% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.96 vs. CAH: 1.44 )
Ranked among companies with meaningful Price/Median PS Value only.
CAH' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.49  Med: 1.61 Max: 3.92
Current: 1.44
0.49
3.92
Price/Peter Lynch Fair Value 2.97
CAH's Price/Peter Lynch Fair Value is ranked lower than
86% of the 21 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.09 vs. CAH: 2.97 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
CAH' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.49  Med: 1.05 Max: 5.08
Current: 2.97
0.49
5.08
Earnings Yield (Greenblatt) (%) 7.57
CAH's Earnings Yield (Greenblatt) (%) is ranked higher than
70% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.10 vs. CAH: 7.57 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CAH' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 3.9  Med: 9.50 Max: 17.9
Current: 7.57
3.9
17.9
Forward Rate of Return (Yacktman) (%) 12.13
CAH's Forward Rate of Return (Yacktman) (%) is ranked lower than
52% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.68 vs. CAH: 12.13 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CAH' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 4.5  Med: 10.00 Max: 21
Current: 12.13
4.5
21

More Statistics

Revenue(Mil) $112423
EPS $ 4.11
Beta0.79
Short Percentage of Float2.54%
52-Week Range $74.73 - 91.91
Shares Outstanding(Mil)329.33

Analyst Estimate

Jun16 Jun17 Jun18
Revenue(Mil) 120,799 128,208 137,104
EPS($) 5.28 5.98 6.75
EPS without NRI($) 5.28 5.98 6.75

Latest Earnings Webcast

» More Conference Calls

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:ABC, MCK, SHTDF, HSIC, PDCO » details
Traded in other countries:CLH.Germany,
Cardinal Health Inc is an Ohio corporation formed in 1979. The Company with its subsidiaries is a healthcare services and products company that improves the cost-effectiveness of health care. Its helps pharmacies, hospitals, and other healthcare providers focus on patient care while reducing costs, enhancing efficiency and improving quality. It also provides medical products to patients in the home. The Company manages its business in two segments: Pharmaceutical and Medical. Pharmaceutical segment distributes generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products in the United States. This segment also operates nuclear pharmacies and cyclotron facilities, provides pharmacy operations, medication therapy management and patient outcomes services to hospitals and other healthcare providers, provides services to healthcare companies supporting the marketing, distribution and payment for specialty pharmaceutical products and manufacturers and repackages generic pharmaceuticals and over-the-counter healthcare products. This segment also imports and distributes pharmaceuticals, over-the-counter healthcare and consumer products as well as provides specialty pharmacy and other services in China. Medical segment distributes medical, surgical and laboratory products and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States, Canada and China and to patients in the home in the United States. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products, which are sold in the United States, Canada, Europe and other regions internationally. The Company's customer is CVS Health. In the Pharmaceutical segment, it competes with wholesale distributors with national reach (including McKesson Corporation and AmerisourceBergen Corporation), regional wholesale distributors, self-warehousing chains, specialty distributors, third-party logistics companies, companies that provide services supporting the development, marketing, distribution and payment for specialty pharmaceutical products and nuclear pharmacies, among others. In addition, the Pharmaceutical segment has experienced competition from a number of organizations offering generic pharmaceuticals, including telemarketers. It also competes with manufacturers that sell all or part of their product offerings directly. In the Medical segment, it competes with many different national medical product distributors, including Owens & Minor, Inc., McKesson Corporation and Medline Industries, Inc. It competes with regional medical product distributors and companies that distribute medical products to patients in the home as well as third-party logistics companies. It competes with manufacturers that sell all or part of their product offerings directly. Competitors of the Medical segment's manufacturing and procedural kit businesses
» More Articles for NYSE:CAH

Headlines

Articles On GuruFocus.com
A Short-Term Problem Creates Long-Term Opportunity in Lannett Company Jan 12 2016 
Cardinal Health: Dividend Aristocrats Part 17 of 52 Oct 29 2015 
The Case for Investing in AmerisourceBergen Aug 13 2015 
Weekly CEO Sells Highlight: Cardinal Health Inc, Bank of the Ozarks Inc, Walt Disney Co, CBIZ Inc. May 17 2015 
Why Hedge Funds Are Betting On AmerisourceBergen Apr 10 2015 
Johnson & Johnson Has A Potential Buyer For Its Medical Devices Unit Feb 24 2015 
Cardinal Health, Inc. (CAH) Dividend Stock Analysis Dec 17 2014 
AmerisourceBergen a Key Player in the Pharma Industry Dec 10 2014 
Dividend Aristocrats In Focus Part 26 of 54: Walgreens Oct 23 2014 
Dividend Aristocrats In Focus Part 20 of 54: Cardinal Health Oct 16 2014 

More From Other Websites
Traders look for floor in Cardinal Health Feb 11 2016
Community Pharmacists Sync to Improve Patient Results and Business Operations Feb 11 2016
Technical Insights on Equity Movements - Research Reports on CSX Corp., Franklin Resources, Cardinal... Feb 10 2016
CARDINAL HEALTH INC Financials Feb 06 2016
Cardinal Health Expert Shares How Hospitals Can Prepare For 340B Drug Pricing Program Changes Feb 04 2016
CARDINAL HEALTH INC Files SEC form 10-Q, Quarterly Report Feb 02 2016
Cardinal Health Board of Directors Approves Quarterly Dividend Feb 02 2016
Cardinal Health, Inc. Earnings Analysis: Q2, 2016 By the Numbers Feb 02 2016
Earnings Recap For February 1 Feb 01 2016
Edited Transcript of CAH earnings conference call or presentation 1-Feb-16 1:30pm GMT Feb 01 2016
[$$] Cardinal Health Revenue Rises 23% Feb 01 2016
Cardinal Health Trumps Q2 Earnings, Sales Estimates Feb 01 2016
Will Cardinal Health (CAH) Stock Be Helped by Earnings Beat? Feb 01 2016
Cardinal Health (CAH) Beats Q2 Earnings & Sales Feb 01 2016
Early movers: AET, STR, CAH, TWTR, RH, YHOO & more Feb 01 2016
Cardinal Health beat profit and sales expectations Feb 01 2016
Cardinal Health Reports Second-Quarter Results For Fiscal 2016 Feb 01 2016
Cardinal tops Street 2Q forecasts Feb 01 2016
Cardinal tops Street 2Q forecasts Feb 01 2016
Q2 2016 Cardinal Health Inc Earnings Release - Before Market Open Feb 01 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK